silicon phthalocyanine pc4 has been researched along with Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baron, ED; Colussi, VC; Cooper, KD; Fu, P; Hanneman, KK; Hsia, AH; Malbasa, CL; Miller, JD; Oleinick, NL; Santo-Domingo, D | 1 |
1 trial(s) available for silicon phthalocyanine pc4 and Carcinoma
Article | Year |
---|---|
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cohort Studies; Female; Humans; Indoles; Male; Middle Aged; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2010 |